摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,4-Bis-(2-methyl-quinolin-4-yl)-[1,4]-diazepan-6-carboxamide | 220364-70-5

中文名称
——
中文别名
——
英文名称
1,4-Bis-(2-methyl-quinolin-4-yl)-[1,4]-diazepan-6-carboxamide
英文别名
1,4-Bis(2-methylquinolin-4-yl)-1,4-diazepane-6-carboxamide
1,4-Bis-(2-methyl-quinolin-4-yl)-[1,4]-diazepan-6-carboxamide化学式
CAS
220364-70-5
化学式
C26H27N5O
mdl
——
分子量
425.533
InChiKey
DQWIILYERUHAGH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.9
  • 重原子数:
    32
  • 可旋转键数:
    3
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.27
  • 拓扑面积:
    75.4
  • 氢给体数:
    1
  • 氢受体数:
    5

反应信息

点击查看最新优质反应信息

文献信息

  • AMINOPYRIDINE DERIVATIVE
    申请人:Tsukamoto Tetsuya
    公开号:US20130005710A1
    公开(公告)日:2013-01-03
    The present invention provides a novel aminopyridine derivative that is excellent in pharmaceutical effects such as a neuroprotective effect, a neurogenesis or nerve regeneration promoting effect, and a cognitive function improving effect and, preferably, is low toxic and delivered at a high rate to the central nervous system. Specifically, the present invention provides a compound represented by the formula (I), wherein ring A represents a monocyclic aromatic hydrocarbon ring or the like; ring B may further have a substituent(s); ring D represents a monocyclic aromatic hydrocarbon ring or the like; L represents a bond, or a methylene group or the like; X represents —NRa- or the like, wherein Ra represents a hydrogen atom or the like; n represents 1 or 2; and R 1 to R 3 each represent a hydrogen atom or the like, wherein ring A and ring D each may be condensed with another ring to form a condensed ring which may have a substituent(s), and ring A-L- in the formula (I) may be bonded to X, provided that when ring A is pyrazole which may be substituted and ring D is benzene which may be substituted, L is a bond; or a salt thereof.
    本发明提供了一种新型的氨基吡啶衍生物,其在药理作用方面表现出色,如神经保护作用、神经发生或神经再生促进作用和认知功能改善作用,并且最好是低毒性并以高速递送到中枢神经系统。具体而言,本发明提供了一种由式(I)表示的化合物,其中环A表示单环芳香烃环或类似物;环B可以进一步具有取代基;环D表示单环芳香烃环或类似物;L表示键合或亚甲基基团或类似物;X表示-NRa-或类似物,其中Ra表示氢原子或类似物;n表示1或2;R1至R3各自表示氢原子或类似物,其中环A和环D各自可以与另一个环融合形成融合环,该融合环可以具有取代基,式(I)中的环A-L-可以与X键合,但当环A为可能被取代的吡唑环,环D为可能被取代的苯环时,L为键合;或其盐。
  • US5866562A
    申请人:——
    公开号:US5866562A
    公开(公告)日:1999-02-02
  • Ring-bridged bis-quinolines
    申请人:Bayer Aktiengesellschaft
    公开号:US05866562A1
    公开(公告)日:1999-02-02
    The present invention relates to ring-bridged bis-quinolines of the general formula (I): ##STR1## in which the indicated substituents are as defined in the description. The invention also provides a process for the preparation of compounds of the formula (I), their use for the preparation of drugs, and drugs containing said compounds.
    本发明涉及一般式(I)的环桥联双喹啉化合物:##STR1## 其中所示的取代基如描述中所定义。该发明还提供了一种制备一般式(I)化合物的方法,以及这些化合物用于制备药物和含有这些化合物的药物。
查看更多